๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
OAB occurs in approximately 50% to 75% of men with BPO and up to 38% of men...
Status
Completed
Location
Samsung Medical Center
Start Date
2009-05
Trial ID
NCT00922506
Treatments Being Tested
Post-traumatic stress disorder (PTSD) affects many individuals who experien...
Status
Active Not Recruiting
Location
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Start Date
2018-06-04
Trial ID
NCT03539614
Pheochromocytoma is a rare, catecholamine (ex. adrenaline) secreting tumor ...
Status
Completed
Location
University of California, Los angeles
Start Date
2017-05-05
Trial ID
NCT03176693
Treatments Being Tested
Cannabis use disorder (CUD) is a significant and expanding health problem, ...
Status
Completed
Location
VA Puget Sound Health Care System
Start Date
2020-11-09
Trial ID
NCT04721353
Treatments Being Tested
The goal of this study is to conduct a prospective controlled trail of four...
Status
Unknown
Location
Naval Medical Center San Diego
Start Date
2008-01
Trial ID
NCT00713739
Treatments Being Tested
This study was recommended by NICE, as part of its 2006 guidance for the tr...
Status
Unknown
Location
NHS Ayrshire
Start Date
2009-05
Trial ID
NCT02369081
Treatments Being Tested
To test whether specific aspects of the attention-enhancing effects of nico...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-03
Trial ID
NCT03416569
Treatments Being Tested
The purpose of this study is to examine whether doxazosin will attenuate th...
Status
Completed
Location
Yale Center for Clinical Investigations, Yale University
Start Date
2013-02
Trial ID
NCT01730846
Treatments Being Tested
The purpose of this study is to see if avanafil causes any changes in blood...
Status
Completed
Location
MDS Pharma Services Inc.,
Start Date
2010-02
Trial ID
NCT01100021
Treatments Being Tested